Skip to main content
logo
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
25.21
-0.40 (-1.56%)
At close: Aug 31, 2026, 4:00 PM EDT
25.21
0.00 (0.00%)
Pre-market: Sep 1, 2026, 4:28 AM EDT

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
North America Revenue
396.54M377.00M340.46M
Latin America Revenue
175.36M170.00M130.71M
Europe Revenue
123.88M108.00M80.12M
Asia-Pacific Revenue
21.15M18.00M8.93M
Revenue (Other)
279.00K--230.00K
Revenue (Total)
717.21M673.00M560.00M

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Crysvita Revenue
187.00M177.00M134.71M
Dojolvi Revenue
101.28M96.00M88.19M
Evkeeza Revenue
72.72M59.00M32.16M
Mepsevii Revenue
37.00M37.00M30.35M
Total Product Revenue
397.99M369.00M285.42M
Crysvita Royalty Revenue
318.94M304.00M274.82M
Revenue (Other)
279.00K--230.00K
Revenue (Total)
717.21M673.00M560.00M